Imjudo 25 MG per 1.25 ML Injection

RxCUI: 2619326
RxNorm name: Imjudo 25 MG per 1.25 ML Injection
Display name: Imjudo 25 MG per 1.25 ML Injection
Full name: Imjudo 25 MG per 1.25 ML Injection
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:01

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761289	Imjudo	tremelimumab-actl	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
IMJUDO	TREMELIMUMAB	AstraZeneca Pharmaceuticals LP	6690679c-be2f-4588-a2e4-89fff74dd6be	2024-07-24	Warnings, Adverse reactions	Exact identifier rxcui: 2619326

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
6690679c-be2f-4588-a2e4-89fff74dd6be	Imjudo 25 MG per 1.25 ML Injection	SY	14	These highlights do not include all the information needed to use IMJUDO safely and effectively. See full prescribing information for IMJUDO. IMJUDO ® (tremelimumab-actl) injection, for intravenous use Initial U.S. Approval: 2022	20240724
6690679c-be2f-4588-a2e4-89fff74dd6be	IMJUDO 25 MG in 1.25 ML Injection	PSN	14	These highlights do not include all the information needed to use IMJUDO safely and effectively. See full prescribing information for IMJUDO. IMJUDO ® (tremelimumab-actl) injection, for intravenous use Initial U.S. Approval: 2022	20240724
6690679c-be2f-4588-a2e4-89fff74dd6be	Imjudo 20 MG/ML per 1.25 ML Injection	SY	14	These highlights do not include all the information needed to use IMJUDO safely and effectively. See full prescribing information for IMJUDO. IMJUDO ® (tremelimumab-actl) injection, for intravenous use Initial U.S. Approval: 2022	20240724
6690679c-be2f-4588-a2e4-89fff74dd6be	1.25 ML tremelimumab-actl 20 MG/ML Injection [Imjudo]	SBD	14	These highlights do not include all the information needed to use IMJUDO safely and effectively. See full prescribing information for IMJUDO. IMJUDO ® (tremelimumab-actl) injection, for intravenous use Initial U.S. Approval: 2022	20240724